CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk factor" sections of filings, contrasting with their publicly positive ...

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

Companies are telling their investors how President Donald Trump’s plan to radically remake the US government poses new risks ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella.

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

CVS Health CEO David Joyner went on the defense of the pharmacy benefit management industry on the company's fourth-quarter earnings call Wednesday morning. PBMs have been under intense scrutiny ...

Wall Street appears to like CVS (CVS) CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday.